,trastuzumab deruxtecan
Daiichi Sankyo,AstraZeneca
['bcsm']
literally got goosebumps listening to this outstanding data! can't wait to start offering tdxd for the subset of her2-low patients. #asco22 #bcsm 
Breast Medical Oncologist, Women & Infants Hospital | Assistant Professor of Medicine, Brown University | Alum- Roswell Park Cancer Institute. Views are my own